JD HEALTH's stock soared 5.26% during intraday trading on Friday, following the release of its annual financial results.
The company reported a profit attributable to shareholders of 5.375 billion yuan for the year, representing a significant increase of 29.16% compared to the previous year. Additionally, JD HEALTH launched over 100 new drugs for the first time during the period, signaling growth in its product portfolio and business expansion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments